menu
MENU
Contact Us
Menu
Introduction
Team & Board of Director
Partners
Investors
Latest News
Overview
Intranasal Vaccines
Asthma Immunotherapy
Respiratory Antiviral Immunotherapy
Contact us
Back to Investors
M.O.P.S. #6709
2025 Annual Report
2026-04-30
2025
2025 Finacial Statements
2026-02-26
2025S2 Finacial Statements
2025-08-12
2024 Annual Report
2025-04-30
2024
2024 Finacial Statements
2025-03-13
2024S2 Finacial Statements
2024-08-12
2023 Finacial Statements
2024-03-18
2023
2023S2 Finacial Statements
2023-08-14
